Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012

Justin Xavier Moore, Ninad Chaudhary, Tomi Akinyemiju, Justin Xavier Moore, Ninad Chaudhary, Tomi Akinyemiju

Abstract

Introduction: Metabolic syndrome is a cluster of cardiometabolic risk factors associated with increased risk of multiple chronic diseases, including cancer and cardiovascular disease. The objectives of this study were to estimate the prevalence of metabolic syndrome overall, by race and sex, and to assess trends in prevalence from 1988 through 2012.

Methods: We analyzed data from the National Health and Nutrition Examination Survey (NHANES) for 1988 through 2012. We defined metabolic syndrome as the presence of at least 3 of these components: elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, high blood pressure, and elevated fasting blood glucose. Data were analyzed for 3 periods: 1988-1994, 1999-2006, and 2007-2012.

Results: Among US adults aged 18 years or older, the prevalence of metabolic syndrome rose by more than 35% from 1988-1994 to 2007-2012, increasing from 25.3% to 34.2%. During 2007-2012, non-Hispanic black men were less likely than non-Hispanic white men to have metabolic syndrome (odds ratio [OR], 0.77; 95% confidence interval [CI], 0.66-0.89). However, non-Hispanic black women were more likely than non-Hispanic white women to have metabolic syndrome (OR, 1.20; 95% CI, 1.02-1.40). Low education level (OR, 1.56; 95% CI, 1.32-1.84) and advanced age (OR, 1.73; 95% CI, 1.67-1.80) were independently associated with increased likelihood of metabolic syndrome during 2007-2012.

Conclusion: Metabolic syndrome prevalence increased from 1988 to 2012 for every sociodemographic group; by 2012, more than a third of all US adults met the definition and criteria for metabolic syndrome agreed to jointly by several international organizations.

Figures

Figure 1
Figure 1
Prevalence of metabolic syndrome among US adults, National Health and Nutrition Examination Survey (NHANES), 1988–2012. Metabolic syndrome was defined by using the criteria agreed to jointly by the International Diabetes Federation; the National Heart, Lung, and Blood Institute in the United States; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity (18). Abbreviation: SE, standard error. [Table: see text]
Figure 2
Figure 2
Prevalence of metabolic syndrome among US adults over time by race/ethnicity–sex and age group, National Health and Nutrition Examination Survey (NHANES), 1988–2012. Metabolic syndrome was defined by using the criteria agreed to jointly by the International Diabetes Federation; the US National Heart, Lung, and Blood Institute in the United States; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity (18). Abbreviation: SE, standard error. [Table: see text]

References

    1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486–97. 10.1001/jama.285.19.2486
    1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol 2010;56(14):1113–32. 10.1016/j.jacc.2010.05.034
    1. Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic syndrome and breast cancer in the Me-Can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010;19(7):1737–45. 10.1158/1055-9965.EPI-10-0230
    1. Borena W, Strohmaier S, Lukanova A, Bjørge T, Lindkvist B, Hallmans G, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 2012;131(1):193–200. 10.1002/ijc.26338
    1. Borena W, Edlinger M, Bjørge T, Häggström C, Lindkvist B, Nagel G, et al. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One 2014;9(2):e89368. Erratum in PLoS One 2014;9(7):e102291. 10.1371/journal.pone.0089368
    1. Lindkvist B, Johansen D, Stocks T, Concin H, Bjørge T, Almquist M, et al. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer 2014;14(1):103. 10.1186/1471-2407-14-103
    1. Stocks T, Bjørge T, Ulmer H, Manjer J, Häggström C, Nagel G, et al. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol 2015;44(4):1353–63. 10.1093/ije/dyv001
    1. Ulmer H, Bjørge T, Concin H, Lukanova A, Manjer J, Hallmans G, et al. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol 2012;125(2):330–5. 10.1016/j.ygyno.2012.01.052
    1. Nagel G, Stocks T, Späth D, Hjartåker A, Lindkvist B, Hallmans G, et al. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol 2012;91(10):1519–31. 10.1007/s00277-012-1489-z
    1. Almquist M, Johansen D, Björge T, Ulmer H, Lindkvist B, Stocks T, et al. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 2011;22(5):743–51. 10.1007/s10552-011-9747-2
    1. Johansen D, Stocks T, Jonsson H, Lindkvist B, Björge T, Concin H, et al. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev 2010;19(9):2307–17. 10.1158/1055-9965.EPI-10-0234
    1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28(7):1769–78. 10.2337/diacare.28.7.1769
    1. Wu SH, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol 2010;25(6):375–84. Erratum in Eur J Epidemiol 2010;25(9):669. 10.1007/s10654-010-9459-z
    1. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28(11):2745–9. 10.2337/diacare.28.11.2745
    1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287(3):356–9. 10.1001/jama.287.3.356
    1. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003;163(4):427–36. 10.1001/archinte.163.4.427
    1. Yang L, Colditz GA. Prevalence of overweight and obesity in the United States, 2007–2012. JAMA Intern Med 2015;175(8):1412–3. 10.1001/jamainternmed.2015.2405
    1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640–5. 10.1161/CIRCULATIONAHA.109.192644
    1. National Health and Nutrition Examination Survey data. Hyattsville (MD): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2016. . Accessed November 1, 2016.
    1. Current population survey (CPS) definitions and explanations. US Census Bureau. . Accessed November 1, 2016.
    1. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol 2013;62(8):697–703. 10.1016/j.jacc.2013.05.064
    1. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 2015;313(19):1973–4. 10.1001/jama.2015.4260
    1. Strath S, Swartz A, Parker S, Miller N, Cieslik L. Walking and metabolic syndrome in older adults. J Phys Act Health 2007;4(4):397–410. 10.1123/jpah.4.4.398
    1. Mankowski RT, Aubertin-Leheudre M, Beavers DP, Botoseneanu A, Buford TW, Church T, et al. Sedentary time is associated with the metabolic syndrome in older adults with mobility limitations — The LIFE Study. Exp Gerontol 2015;70:32–6. 10.1016/j.exger.2015.06.018
    1. Denys K, Cankurtaran M, Janssens W, Petrovic M. Metabolic syndrome in the elderly: an overview of the evidence. Acta Clin Belg 2009;64(1):23–34. 10.1179/acb.2009.006
    1. Akinyemiju T, Jha M, Moore JX, Pisu M. Disparities in the prevalence of comorbidities among US adults by state Medicaid expansion status. Prev Med 2016;88:196–202. 10.1016/j.ypmed.2016.04.009
    1. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 2015;(219):1–8.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere